JUDAS PRIEST’s ROB HALFORD Receives Second Dose Of COVID-19 Vaccine

Rob Halford COVID-19 Vaccine

JUDAS PRIEST singer Rob Halford has received his second dose of the COVID-19 vaccine.

Last night (March 22), the 69-year-old singer, who lives in Phoenix, Arizona, took to his social media to share a photo of him holding his “Vaccination Record Card” while sitting in his car, and he wrote in an accompanying message: “‘done’ #heavymetal #ink #tattoo #metal #motivation #boost #selfcare #maniacs #staypositive #community #defender #you #me #us #love #family #friends #fans #one #world #peace #respect #all.”

JUDAS PRIEST have postponed most of their previously announced fall 2020 U.S. tour dates to the summer/fall of 2021. Tickets and dates for the tour can be find here.

Halford recently spoke about the progress of the songwriting sessions for the band’s follow-up to 2018’s Firepower album.

He said during a recent appearance on Lazer 103.3 radio station: “We’ve already started work on it. We had some great writing sessions in the early part of this year until the world came to a stop in late March. I came back here [home] to Phoenix just to chill and relax for a bit and get ready for another writing session. ‘Cause that’s what we need to do as a band.

“You make a bunch of work and then you walk away from it and then you go back to it later and re-analyze it and continue the growth of the record,” he continued. “That’s what we were doing then, and we’re still doing it now — we’re still putting bits and pieces together.

“It’s an unusual way of making a record, but we’re not the only band that’s going through this situation in terms of creativity. You can’t let this pandemic stop you; you’ve gotta try and still get as much out of life as you can.”

Firepower was released in 2018 and is the band’s first studio album since 1988’s Ram It Down to be produced by Tom Allom and the first one with Andy Sneap as co-producer. The album sold around 49,000 copies in the United States within its first week of release, debuting at No. 5 on the Billboard 200 chart, making it the band’s highest-charting album in the US.